Axillary Recurrence After a Tumor-Positive Sentinel Lymph Node Biopsy Without Axillary Treatment: A Review of the Literature

@inproceedings{Francissen2012AxillaryRA,
  title={Axillary Recurrence After a Tumor-Positive Sentinel Lymph Node Biopsy Without Axillary Treatment: A Review of the Literature},
  author={Claire M. T. P. Francissen and Pim J. M. Dings and Thijs van Dalen and Luc J. A. Strobbe and Hanneke W. M. van Laarhoven and Johannes H W de Wilt},
  booktitle={Annals of Surgical Oncology},
  year={2012}
}
Sentinel lymph node biopsy (SLNB) has become standard of care as a staging procedure in patients with invasive breast cancer. A positive SLNB allows completion axillary lymph node dissection (cALND) to be performed. The axillary recurrence rate (ARR) after cALND in patients with positive SLNB is low. Recently, several studies have reported a similar low ARR when cALND is not performed. This review aims to determine the ARR when cALND is omitted in SLNB-positive patients. A literature search was… CONTINUE READING

From This Paper

Figures, tables, and topics from this paper.

Citations

Publications citing this paper.
Showing 1-10 of 18 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 68 references

Comparison of sentinel lymph node biopsy alone and completion axillary lymph node dissection for node-positive breast cancer.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology • 2009
View 15 Excerpts
Highly Influenced

Similar Papers

Loading similar papers…